← Back to Search

Intensive Clinic Management (ICM) for Hypertension (TEAMS-BP Trial)

Waitlist Available
Led By Cheryl Bushnell, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 3 month
Awards & highlights

TEAMS-BP Trial Summary

This trial compares two approaches to managing BP after stroke: Telehealth Monitoring vs Clinic Management. The goal is to find which is better at controlling BP and helping patients manage it.

Eligible Conditions
  • Secondary Hypertension

TEAMS-BP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of participants with 3-month SBP control
Secondary outcome measures
Mean change in Partners in Health Scale (PIH) score at 3 months
Mean change in systolic blood pressure (SBP) at 3 months
Proportion of participants attending both visits among those who are randomized in the study
+5 more

TEAMS-BP Trial Design

2Treatment groups
Experimental Treatment
Group I: Intensive tailored telehealth management (ITTM)Experimental Treatment1 Intervention
Group II: Intensive Clinic Management (ICM)Experimental Treatment1 Intervention
First Studied
Drug Approval Stage
How many patients have taken this drug
Intensive tailored telehealth management (ITTM)
Intensive Clinic Management (ICM)

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,241 Previous Clinical Trials
1,004,163 Total Patients Enrolled
20 Trials studying Hypertension
34,408 Patients Enrolled for Hypertension
Cheryl Bushnell, MDPrincipal InvestigatorWake Forest Health Sciences
4 Previous Clinical Trials
1,705 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible to join the clinical trial at this point in time?

"Per the information posted on clinicaltrials.gov, this research endeavour is actively recruiting participants. This trial was initially published on October 11th 2022 and recently revised on October 28th 2022."

Answered by AI

Does this experimental protocol permit elderly participants?

"This trial's admission requirements call for participants aged between 18 and 75. Sub-18s have 54 studies open to them, whereas individuals 65+ are eligible for 662 different clinical trials."

Answered by AI

What are the eligibility criteria for joining this clinical study?

"This clinical trial seeks 100 individuals with secondary hypertension who are aged between 18 and 75. To qualify, candidates must demonstrate a history of ischemic stroke or spontaneous haemorrhagic stroke; be proficient in English or Spanish; agree to install and use physical activity monitoring software on their phone; give written consent for the study, have access to a functioning smartphone with data connectivity, as well as commit to attending all required visits."

Answered by AI

How many participants are currently enrolled in this research project?

"Affirmative. According to the clinicaltrials.gov listing, this experiment is still enrolling participants and requires 100 volunteers at a single location. The trial was initially posted on October 11th 2022 with its last update occurring 17 days later on October 28th 2022."

Answered by AI
~30 spots leftby Apr 2025